September 2012

Dear Colleagues: 

The IASLC welcomes our newly appointed Chief Editor for our Journal of Thoracic Oncology, Dr. Alex Adjei, who will succeed Dr. James Jett (see below). With rapid developments in digital technologies new opportunities have arisen for our journal and our other educational activities. JTO will now also be available as an “app” for mobile devices (see below). 

The IASLC nomination process for the 2013 Board of Directors election is currently ongoing (see below). 

Our regional meetings are continuing with great success; The IASLC/ASTRO/ASCO Multidisciplinary Conference in Chicago in September had 800 participants and very exciting scientific presentations. The Asian Pacific Lung Cancer Conference in Fukuoka, Japan in November is expected to host more than 1.000 participants. 

As we move into annual World Conferences on Lung Cancer, the conference planned for Vienna has been moved to 2016; several good candidate host cities for the 2017 conference in Asia are currently being evaluated. The decision for the WLCC site 2017 will be made by the IASLC BOD in November. 

IASLC is moving into the 40 year anniversary celebration. We hope that the BOD’s initiative to mark this event by establishing the Heine Hansen Fellowship will get wide support in order to stimulate young investigators to successful careers in translational/clinical studies of thoracic malignancies. Several other initiatives are already ongoing in preparation for the 40 year anniversary; a history of IASLC and the history of lung cancer during this period of time are under preparation. 

Fred R. Hirsch, MD, PhD 

Editor, IASLC Newsletter 

5th APLCC ITMIG IASLC Conference, November 26-28, 2012 

IASLC is now a CME Provider 

The International Association for the Study of Lung Cancer (IASLC) has been awarded Provisional Accreditation as a Continuing Medical Education (CME) provider by the Accreditation Council for Continuing Medical Education (ACCME). 

A two-year term of Provisional Accreditation is the highest award possible for initial applicants such as the IASLC. IASLC was found to fulfill all accreditation requirements set forth by ACCME and is certified as a CME provider from July 2012 until July 31, 2014. 

IASLC New JTO Editor 

Alex Adjei, MD, PhD has been appointed new Chief Editor for the Journal of Thoracic Oncology per January 1, 2013. Dr. Adjei is the Director of Roswell Park Cancer Center in Buffalo, NY, USA. Dr. Adjei has extensive editorial experience as member of Editorial Board of many journals and has also an extensive scientific experience in the field, particularly in phase I studies and translational research. Dr. Adjei is also a current member of the IASLC Board of Directors. 




Tetsuya Mitsudomi, MD. PhD has accepted a new position per May 1st , 2012 as Professor of Thoracic Surgery, Kinki University, Faculty of Medicine, Osaka-Sayama, Japan. Dr. Mitsudomi left his position as Vice Director of Aichi Cancer Center Hospital, Nagoya, Japan after 16 years. Dr. Mitsudomi is currently serving as a member of IASLC BOD. His new E-mail address is




Please remember to pay your 2012 IASLC membership fee - $200 

Registering online is fast and easy! Visit for more information. 

IASLC members will be sent renewal reminders and invoices. Register now so there will no interruption to your JTO subscription, and to receive discounts on 2012 meeting fees. Please contact the Membership Department if you need any assistance paying your dues: 

IASLC 40th Anniversary Professor Heine H. Hansen Fellowship

As we embark on the next 40 years of the International Association for the Study of Lung Cancer, we pause to celebrate the past 40 years. The IASLC Board of Directors commemorates this notable time in the IASLC history by a 40th Anniversary Campaign to raise money for an additional fellowship in order to strengthen our education of the next generation lung cancer investigators. This fellowship will be named in Professor Heine H. Hansen’s honor. Professor Hansen was instrumental in the development of the IASLC. He was Congress President of the 2nd World Conference on Lung Cancer in Copenhagen in 1980. He served on the Board of Directors from 1985 to 1994 and served as the President from 1988-1991. Prof. Hansen was the first Executive Director of the IASLC (1991-2001) and was also the founder of the first IASLC journal Lung Cancer in 1985. He was a leader in developing international guidelines for the staging and treatment of small cell lung cancer and arranged many international workshops in this field. He received the IASLC Merit Award in 1997 and became the first Honorary Member in 2003. The IASLC fellowships benefit young researchers with the intention of encouraging innovative research in lung cancer prevention and translational medicine worldwide. Board members have made significant contributions to kick off this campaign. Please show your commitment to the IASLC 40th Anniversary Campaign by contributing to the Professor Heine H. Hansen Fellowship. 

Heine H. Hansen, M.D., Ph.D. (1938-2011)

Name: ________________________________________________________

Commitment Amount: USD 1,000 500 100 50 Other __________

Send payments to: IASLC

13100 E. Colfax Ave Unit 10

Aurora, CO 80011  

IASLC Web-based Education Programs 


In 2011, the Journal for Thoracic Oncology published the “International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma,” issued by a multidisciplinary team of lung cancer specialists. To better understand the general implications of this new classification, and the issues affecting specific specialties, please join us for this On-Demand Webinar Series. 

Module 1 - Introducing The New IASLC/ATS/ERS Lung Adenocarcinoma Classification

Module 2 - Implications of the New IASLC/ATS/ERS Classification; Module 3 - Highlights for the Pathologist; Module 4 - Highlights for the Radiologist; Module 5 - Case Studies for the Practicing Clinician 

Please go to for more details 

Women and Lung Cancer - CME-certified Audio-guided Web course 

The International Association for the Study of Lung Cancer (IASLC) has partnered with joint sponsors Penn State College of Medicine and Rockpointe to bring a CME-certified webcourse to oncologists caring for patients with lung cancer. 

Click here to view activity:

JTO is now available as an iPad app, and can be downloaded from the App Store. 

Starting with September, each issue will be available within the app the same day it is mailed and posted at The first few issues will be free, but soon access will be restricted to members and paid subscribers. The same log in used for will be used to sign into the app when that feature is enabled. If you haven’t registered for a user name and password, you can do that any time at 

The app includes every page of the journal in a format optimized for reading on an iPad. Users can pinch and zoom to increase the size of figures and tables, scroll through the issue with the “quick view” feature, link directly from the table of contents to articles, and email articles to colleagues. Since the issue is downloaded in its entirety, the journal can be read later even if the iPad is in “airplane” mode or no connectivity is available. Issues can be saved on the iPad, or archived after reading and downloaded again at any time, as long as the user is still an IASLC member or paid subscriber. Notifications can be enabled to provide updates when a new issue is available. 

We hope you will download and use JTO on your iPad. All of the features that make JTO so valuable to your practice are included, but now you can take issues with you whenever you have your iPad. 

IASLC Staging Manual: 

The IASLC Staging Manual and Handbook in Thoracic Oncologic has now surpassed 35,000 copies sold worldwide. In addition, the Staging Posters and Reference Cards continue to be popular reference aids of the 7th edition staging system for practitioners and tumor boards. IASLC members can continue to order these publications and products at special member pricing (; contact for further information). 

In addition, translations of these publications have been completed or are in process in multiple languages: Chinese, Italian, Japanese, Polish, and Turkish. Discussions about future translations in Spanish, Arabic, and Russian are ongoing. 

The new IASLC Staging Manual has been published in different formats. Several years of work from the IASLC Staging Committee and particularly the chair Dr. Peter Goldstraw, has resulted in a formal staging manual. The book and the “pocket-cards” can be ordered at 




iPhone/iPad Staging Atlas




IASLC Board of Director Election 2013 

In 2013, the IASLC will hold an election for a President-Elect from North America, a Treasurer and 8 new Board members (3 from North America, 3 from Europe, and 2 from Asia/Australia/South America/Africa). The Board of Directors has a total of 15 Directors, 5 each from North America, Europe, and Asia/Australia/South America/Africa. The Board of Directors should be diverse in terms of specialty and gender. Under current bylaws the terms of office are as follows: 

New members of the Board of Directors will be elected for a two-year period 2013-2015, potentially renewable for an additional term. The President-Elect will serve three terms (President-Elect, President and Past President). The Treasurer will serve up to two terms. 

The following board members will remain as elected members of the Board from 2013-2015. 

North America 

Alex Adjei, medical oncology 

Carolyn Dresler, surgery 


Christian Manegold, medical oncology 

Silvia Novello, pulmonology 

Asia/Australia/South America/Africa 

Kazuhiko Nakagawa, medical oncology 

Sumitra Thongprasert, medical oncology 

Tetsuya Mitsudomi, surgery 

The Nominating Committee is seeking nominations for the President-Elect, Treasurer and Board seats. You are encouraged to nominate yourself and/or another IASLC member to one of these positions. 

An ideal candidate is one who is actively engaged in the IASLC and consistently attends the World Conference on Lung Cancer and/or other IASLC conferences, and willing to attend approximately four board meetings per year and to serve on IASLC Committees. 

Additional roles and responsibilities can be found on the IASLC website at 

Nominations will begin on September 1 and close on November 30, 2012. 

To nominate an individual or to self-nominate, please go to the following website to complete the application process. 

Upcoming IASLC Workshops/Meetings 2012- 2015 

5th Asia Pacific Lung Cancer Conference 

November 26-28, 2012 Location: Hilton Sea Hawk, Fukuoka, Japan 

More information: 


15th World Conference on Lung Cancer 

October 27-31, 2013 

Location: Sydney, Australia 

More information: 


16th World Conference on Lung Cancer 

September 4-8, 2015 

Location: Denver, Colorado, USA 

More information: